ATX — Amplia Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00- AU$17.46m
- AU$12.95m
- AU$4.44m
Annual cashflow statement for Amplia Therapeutics, fiscal year end - March 31st, AUD millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Changes in Working Capital | -0.519 | -0.549 | -0.954 | -1.07 | -1.35 |
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -2.09 | -2.92 | -4.4 | -5.29 | -5.13 |
| Capital Expenditures | 0 | -0.005 | -0.014 | -0.018 | -0.002 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | 0 | 0 | -0.012 | -0.041 | 0 |
| Sale of Fixed Assets | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 0 | -0.005 | -0.027 | -0.058 | -0.002 |
| Financing Cash Flow Items | -0.191 | -0.4 | -1.18 | -0.041 | -0.693 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 1.96 | 3.66 | 17.2 | -0.084 | -0.773 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.133 | 0.74 | 12.8 | -5.35 | -5.87 |